Avacta Therapeutics (AIM: AVCT), a life sciences company developing next generation peptide drug conjugates (PDC) targeting ...
Friday morning sees the sixth tournament of the PDC Challenge Tour 2025. The Challenge Tour circuit is open to players who participated in the Q-School but did not win a Tour Card. On this tour, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback